Image de couverture de livre

Anatomical distribution of disease in pN1 prostate cancer with BCR post‐RP: A PSMA‐PET/CT‐based analysis

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Lotte G. Zuur, Katelijne C. C. de Bie, Lieke Wever, Anne‐Claire Berrens, Jean‐Paul A. van Basten, Harm H. E. van Melick, Maarten L. Donswijk, Daniela E. Oprea‐Lager, Wouter V. Vogel, Henk G. van der Poel, André N. Vis, Pim J. van Leeuwen
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	BJUI Compass
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
par: Stijn M. van den Bosch, et autres
Publié: (2026)

Hospital variation in the treatment of cT1a renal cancer
par: Cato Caroline Bresser, et autres
Publié: (2026)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
par: Jeremy Cheng, et autres
Publié: (2025)

PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
par: Nicole Handa, et autres
Publié: (2025)

A population‐based analyses of the evolving management of cN1M0 prostate cancer in the PSMA‐PET era
par: Jennifer Ward, et autres
Publié: (2025)

Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
par: Joshua Yi Min Tung, et autres
Publié: (2026)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
par: Esther H. J. Hamoen, et autres
Publié: (2025)

Ureteroenteric strictures after cystectomy: Side‐specific risk factors and radiological assessment
par: Simone Buchardt Brandt, et autres
Publié: (2024)

99m TcPSMA ‐radioguided surgery in oligorecurrent prostate cancer: the randomised TRACE‐II trial
par: Lotte G. Zuur, et autres
Publié: (2024)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
par: Ruth Pidsley, et autres
Publié: (2024)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
par: Muhammad Imran, et autres
Publié: (2026)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
par: Ansh Bhatia, et autres
Publié: (2024)

Accuracy of warm ischemia time measurement using a surgical intelligence software in partial nephrectomies: A validation study
par: Archan Khandekar, et autres
Publié: (2024)

The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
par: André B. Silva, et autres
Publié: (2026)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
par: Mathew Thakur, et autres
Publié: (2024)

A systematic review and network meta‐analysis comparing Rezūm with transurethral needle ablation and microwave thermotherapy for the management of enlarged prostate
par: Ansh Bhatia, et autres
Publié: (2024)

A pilot study evaluating the safety and efficacy of En‐bloc holmium laser enucleation of the prostate in patients with a history of radiation therapy or high intensity focused ultrasound for management of organ confined prostate cancer with review of the literature
par: Renil S. Titus, et autres
Publié: (2025)

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
par: Alan Priester, et autres
Publié: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
par: Ailene E. Corona, et autres
Publié: (2026)

Contemporary assessment of diagnostic performance and histologic concordance of renal mass biopsy with surgical pathology
par: Mitchell M. Huang, et autres
Publié: (2025)

Racial and socioeconomic disparities from time of diagnosis to treatment for small renal masses
par: Lila G. McGrath, et autres
Publié: (2026)

Primary extragonadal germ cell tumours: Real‐world data from a high‐volume centre
par: Marc Kidess, et autres
Publié: (2026)

Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow‐up analysis of the COVIDSurg‐Cancer study
par: Arjun Nathan, et autres
Publié: (2024)

Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
par: Cameron E. Alexander, et autres
Publié: (2024)

A modified Delphi consensus statement on the role of biopsy in small renal masses
par: Darryl E. Bernstein, et autres
Publié: (2025)

Giant testicular germ‐cell tumours—An analysis of relative incidence and clinical features based on a clinical case series and a survey of the literature
par: Markus Angerer, et autres
Publié: (2026)

Prognostic factors and treatment impact on overall survival in patients with renal neuroendocrine tumour
par: Olamide O. Omidele, et autres
Publié: (2024)

Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort
par: Goran Bencina, et autres
Publié: (2024)

Prevention of lymphoceles using peritoneal flaps during robotic‐assisted radical prostatectomy with pelvic lymph node dissection: A systematic review and meta‐analysis
par: Huseyin Yildiz, et autres
Publié: (2026)

Treatment decision regret after precision prostatectomy: An analysis of patient‐reported outcomes predicting decision regret
par: Kaushik P. Kolanukuduru, et autres
Publié: (2024)

Issue Information
Publié: (2025)

Step‐by‐step: A traction‐based fenestration method for vasoepididymostomy
par: Kosuke Kojo, et autres
Publié: (2025)

Increased risk of bleeding during and after HoLEP in patients with prostate cancer: A multicentre comparative cohort study
par: Angelo Porreca, et autres
Publié: (2025)

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma
par: Anna Brännbäck, et autres
Publié: (2025)

Urinary microbiota diversity and composition in patients with advanced renal cell cancer
par: Frederico Leal, et autres
Publié: (2026)

Racial and socioeconomic disparities in surgical care for post‐prostate cancer treatment complications: A nationwide Medicare‐based analysis
par: Oluwafolajimi Adesanya, et autres
Publié: (2024)

Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
par: Kira Furlano, et autres
Publié: (2024)

A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
par: John Lahoud, et autres
Publié: (2024)

The learning curve of single‐port extraperitoneal robotic radical prostatectomy: Initial experience and outcomes from a newly graduated fellowship‐trained robotic surgeon
par: Jacob S. Hershenhouse, et autres
Publié: (2026)

Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach
par: Harry Collin, et autres
Publié: (2024)